Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.39213 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.3721 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.37449 | 15 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.31761 | 15 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.3286 | 15 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.47126 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.42197 | 16 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.34784 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.33674 | 15 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.35946 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.35632 | 15 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.34222 | 15 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.37236 | 15 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.36401 | 15 |